Key result
Targeted left ventricular lead placement to sites of latest mechanical activation and optimal device programming are crucial to maximize the clinical benefits of cardiac resynchronization therapy.
Why the study?
Does targeted left ventricular lead placement and optimal device programming improve clinical outcomes in heart failure patients receiving cardiac resynchronization therapy?
Does targeted left ventricular lead placement and optimal device programming improve clinical outcomes in heart failure patients receiving cardiac resynchronization therapy?
Optimizing LV lead placement and device programming is crucial to maximize the clinical benefits of cardiac resynchronization therapy and minimize non-response rates.
No takes yet. Share an insight, caveat, or question.
May enhance CRT response via optimization; leaves open need for prospective trials before practice change.
Sokratis Pastromas (2014) conducted a review in Heart failure. Targeted left ventricular lead placement and optimal device programming was evaluated. Targeted left ventricular lead placement to sites of latest mechanical activation and optimal device programming are crucial to maximize the clinical benefits of cardiac resynchronization therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: